Emplicure Ab

Orexo Ab

Diabact Ab

Thomas Lundqvist

Anders Pettersson

Håkan Engqvist

Susanne Bredenberg

Anders Sågström

Anna Dahlgren

Christer Nystrom

Christer Nyström

Anders Petterson

A transdermal drug administration device comprising a drug delivery element () defining a contact surface () for location, in use, against a patient's skin. The drug delivery element () includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.

Transdermal drug administration device

A method of detecting inflammatory processes comprises (a) administering per-orally or per-rectally a composition comprising a diagnostically effective amount of L-[guanido-N]-arginine, L-[guanido-N]-arginine, their mixtures and pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier; (b) collecting a sample of exhaled air, saliva or urine; (c) determiningNO in the air sample or its transformation productsIN-nitrite and/orN-nitrate in the saliva sample or urine. Also disclosed is a corresponding diagnostic composition for use in diagnosing inflammatory processes and a method for its manufacture.

Method and means for detecting inflammatory processes

Diagnostic preparation for detection of helicobacter pylori

Growing community of inventors

Uppsala, Sweden

Thomas Lundqvist